PPAR-gamma antagonist imatinib improves insulin sensitivity
(HealthDay)—Imatinib (Gleevec) blocks CDK5-mediated peroxisome proliferator-activated receptor γ (PPARγ) phosphorylation as an antagonist ligand, improving insulin sensitivity and promoting browning of white adipose tissue, ...
Jan 13, 2016
0
1